VivoSeq
Other

Open Heart Surgery

0

Pipeline Programs

0

Active Trials

0

Companies Involved

Open Heart Surgery is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

88/100

Attrition Rate

10/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

20

clinical trials

Completed14 · 70%
Unknown status4 · 20%
Terminated1 · 5%
Withdrawn1 · 5%

Trial Activity

20 trials

Transversus Thoracic Muscle Plane Block for Open Heart Surgery
Completed··N/A·NCT04094532·48 enrolled
Understanding Dexmedetomidine in Neonates After Open Heart Surgery
Completed··Phase 1·NCT00576381·30 enrolled
Neuroprotection During Open Heart Surgery
Completed··Phase 3·NCT04486690·50 enrolled
Glucose Control in Open Heart Surgery
Completed·UUniversity of Sao Paulo·Phase 1·NCT00370643·98 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)